<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04988438</url>
  </required_header>
  <id_info>
    <org_study_id>2021/1407-03UHD</org_study_id>
    <nct_id>NCT04988438</nct_id>
  </id_info>
  <brief_title>Gastrointestinal Motor Disorders (Esophageal and Anorectal) After COVID-19</brief_title>
  <official_title>Gastrointestinal Motor Disorders (Esophageal and Anorectal) in Patients After COVID-19 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Dubrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Dubrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The patients who had COVID-19 infection, and after that reported for one of the signs of&#xD;
      gastrointestinal disorder (esophageal and anorectal) will be underwent to esophageal and&#xD;
      anorectal motor monitoring investigation (HRM manometry) on standard protocol.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients who had COVID-19 infection, and after that reported for one of the signs of&#xD;
      gastrointestinal (esophageal and anorectal disorder) will be underwent to esophageal and&#xD;
      anorectal motor monitoring investigation (HRM manometry) on standard protocol.&#xD;
&#xD;
      The patients with dysphagia, chest discomfort during swallowing, or chest pain during&#xD;
      swallowing, patients with obstipation, fecal evacuation symptoms, lower stomach discomfort&#xD;
      before defecation etc. will be included in the study. In all of them other gastrointestinal&#xD;
      diseases will be excluded by standard routine laboratory investigation, ultrasound, routine&#xD;
      endoscopy investigation and 24 hours impedance pH-measurement.&#xD;
&#xD;
      After manometric measurement of esophagus and anorectal region to standard protocol by using&#xD;
      MMS-HRM 360 monitoring system with 36 canals catheter for esophagus and 24 canals catheter&#xD;
      for anorectal monitoring, data will be calculated by using statistics.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2023</completion_date>
  <primary_completion_date type="Actual">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of esophageal parameters 1 on manometry</measure>
    <time_frame>120 days</time_frame>
    <description>In esophagus we will measure Upper and lower esophageal sphincter pressure in mmHg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of esophageal parameters 2 on manometry</measure>
    <time_frame>120 days</time_frame>
    <description>In esophagus we will measure Integrated relaxation pressure (IRP) in mmHg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of esophageal parameters 3 on manometry</measure>
    <time_frame>120 days</time_frame>
    <description>In esophagus we will measure Contractile front velocity (CVF) in cm/s.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of esophageal parameters 4 on manometry</measure>
    <time_frame>120 days</time_frame>
    <description>In esophagus we will measure Distal contractile integral (DCI) in mmHg.s.cm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of esophageal parameters 5 on manometry</measure>
    <time_frame>120 days</time_frame>
    <description>In esophagus we will measure Distal latency (DL) in seconds.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of esophageal parameters 6 on manometry</measure>
    <time_frame>120 days</time_frame>
    <description>In esophagus we will measure Peristaltic brake (BR) in cm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of anorectal parameters 1 on manometry</measure>
    <time_frame>2 years</time_frame>
    <description>On anorectal manometry we will measure Resting test pressure in mmHg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of anorectal parameters 2 on manometry</measure>
    <time_frame>2 years</time_frame>
    <description>On anorectal manometry we will measure Squeeze test pressure in mmHg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of anorectal parameters 3 on manometry</measure>
    <time_frame>2 years</time_frame>
    <description>On anorectal manometry we will measure Endurance squeeze test pressure in mmHg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of anorectal parameters 4 on manometry</measure>
    <time_frame>2 years</time_frame>
    <description>On anorectal manometry we will measure recto-anal inhibitory reflex test (RAIR)- relaxation in percent.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of anorectal parameters 5 on manometry</measure>
    <time_frame>2 years</time_frame>
    <description>On anorectal manometry we will measure Push test pressure in mmHg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of anorectal parameters 6 on manometry</measure>
    <time_frame>2 years</time_frame>
    <description>On anorectal manometry we will measure Sensation test with ml in balloon.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of anorectal parameters 7 on manometry</measure>
    <time_frame>2 years</time_frame>
    <description>On anorectal manometry we will measure Balloon expulsion test as positive or negative.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Gastrointestinal Motility Disorder</condition>
  <arm_group>
    <arm_group_label>esophageal manometry</arm_group_label>
    <description>The patients who has previously mentioned symptoms will underwent to manometry monitoring of esophageal and anorectal disorders.&#xD;
For this investigation we have proven normal and standardized manometric values on previous investigations by other authors, so the control group is not needed. We know the normal manometric values (Chicago 3 score).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>anorectal manometry</arm_group_label>
    <description>The patients who has previously mentioned symptoms will underwent to manometry monitoring of esophageal and anorectal disorders.&#xD;
For this investigation we have proven normal and standardized manometric values on previous investigations by other authors, so the control group is not needed. We know the normal manometric values (London protocol).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The patients from 20-80 years, men and women.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with esophageal and anorectal symptoms after COVID 19- infection&#xD;
&#xD;
          -  Patients with worsening of esophageal and anorectal symptom after COVID 19- infection,&#xD;
             but who had previously described esophageal and anorectal symptoms&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other gastrointestinal disease that can influence to results&#xD;
&#xD;
          -  Gastroesophageal reflux&#xD;
&#xD;
          -  H. Pylori infection&#xD;
&#xD;
          -  Bacterial, parasitic, viral and fungal gastrointestinal infection or infestation&#xD;
&#xD;
          -  Myasthenia&#xD;
&#xD;
          -  Scleroderma&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Thyroidal hyperfunction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Žarko B Babić, prof.dr.sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head od Interventional gastroenterology UH Dubrava</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Žarko Babić, prof.dr.sc.</last_name>
    <phone>+38512903390</phone>
    <email>zarko.babic@zg.t-com.hr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marko Banić, prof.dr.sc.</last_name>
    <phone>+38512903390</phone>
    <email>mbanic@kbd.hr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Prof.dr.sc. Žarko Babić, FEBGH</name>
      <address>
        <city>Zagreb</city>
        <state>Select State</state>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Žarko Babić, prof.</last_name>
      <phone>+38512903390</phone>
      <email>zarko.babic@zg.t-com.hr</email>
    </contact>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 27, 2021</study_first_submitted>
  <study_first_submitted_qc>July 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Dubrava</investigator_affiliation>
    <investigator_full_name>Žarko Babić</investigator_full_name>
    <investigator_title>Principal investigator, Clinical professor, Heat of Interventional gastroenterology</investigator_title>
  </responsible_party>
  <keyword>After COVID-19</keyword>
  <keyword>gastrointestinal motility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Motor Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

